Catherine Tsilfidis is a senior scientist in the Regenerative Medicine Program of the Ottawa Hospital Research Institute, and an Associate Professor in the Departments of Ophthalmology and Cellular and Molecular Medicine at the University of Ottawa. She has an active research program that is funded by CIHR, the Foundation Fighting Blindness and the Krembil Foundation, and she currently holds the Don and Joy Maclaren Chair in Vision Research. Her research is aimed at developing a gene therapy strategy that blocks apoptosis and slows down retinal disease progression.
Jack Kitts: CEO of The Ottawa Hospital
Dr. Jack Kitts received his medical degree from the University of Ottawa in 1980. After interning at the University of Toronto, he completed a three year tour as a medical officer in the Canadian Forces before returning to the University of Ottawa to complete specialty training in anesthesia in 1987. Dr. Kitts then joined the medical staff at the Ottawa Civic Hospital as an anesthesiologist and Research Director for the Department of Anesthesia. In 1995 he was appointed Chief of Anesthesia at the Ottawa Civic Hospital and Associate Professor at the University of Ottawa.
In 1998, Dr. Kitts was appointed Vice-President of Medical Affairs and led the medical staff during a complex restructuring in which three hospitals and five large programs were merged into The Ottawa Hospital. He completed his master’s degree in business administration in 2001 and was named President and CEO of The Ottawa Hospital in February 2002. Dr. Kitts continues in that position to this day, managing a staff of 12,000.